DEXPANTHENOL 5% OPHTHALMIC GEL, 10 G
About This Opportunity
TranslatedThis tender is for the procurement of Dexpanthenol 5% Ophthalmic Gel in a 10-gram format. Dexpanthenol, a derivative of pantothenic acid, is commonly used in ophthalmic applications for its moisturizing and healing properties. The gel is intended for use in treating various eye conditions, providing relief from dryness and irritation. Key requirements for bidders may include compliance with specific pharmaceutical standards, quality assurance protocols, and the ability to deliver the product within the stipulated timeframe. It is essential that the product meets all regulatory requirements for ophthalmic medications to ensure safety and efficacy. The tender is likely aimed at suppliers in the pharmaceutical sector, and interested parties should be prepared to demonstrate their capacity to meet the demands of this procurement. Bidders must also provide documentation regarding the manufacturing process, quality control measures, and any relevant certifications. The location of delivery and any logistical considerations may also be outlined in the tender documents. Overall, this procurement represents an opportunity for suppliers to contribute to the healthcare sector by providing a vital product that supports eye health.
This is a supplies contract in the health and medical services and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 587.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender pertains to the procurement of Dexpanthenol 5% ophthalmic gel, packaged in 10-gram containers, intended for use in the healthcare sector in Portugal. Dexpanthenol, a derivative of pantothenic acid, is commonly utilized in ophthalmology for its therapeutic properties, particularly in the treatment of dry eyes and the promotion of corneal healing.
The contracting authority, while not explicitly stated, is expected to align with the public health sector standards, ensuring that the procurement process adheres to the regulations governing public contracts in Portugal. This tender is part of a broader initiative to enhance healthcare accessibility and improve patient treatment options.
Potential bidders are typically required to demonstrate compliance with pharmaceutical manufacturing standards, including Good Manufacturing Practices (GMP). They should provide evidence of regulatory approvals from pertinent health authorities, such as the European Medicines Agency (EMA) or the Infarmed in Portugal. Additionally, bidders may need to submit detailed product specifications, quality assurance protocols, and a comprehensive plan for distribution and delivery timelines.
Interested suppliers should be prepared to engage in a competitive bidding process, showcasing not only their product quality but also their capacity for reliable supply chain management.
This procurement represents a crucial opportunity for pharmaceutical companies specializing in ophthalmic products to contribute to Portugal’s healthcare system, ultimately enhancing the quality of care provided to patients requiring ocular therapeutic solutions.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 20, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Almada-Seixal, EPE
Unidade Local de Saúde de Almada-Seixal, EPE has issued 1,414 procurement notices on BidsFactory, including 3 currently open and 1,382 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to DAVI II - FARMACÊUTICA, S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Almada-Seixal, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €587. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.